Adults 12 to 17, any sex, with Adolescent Behavior or Asthma. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Asthma-specific Quality of LifePrimary· 6 months
PedsQL (paediatric quality of life inventory) - asthma module - presented as a total score with a higher score indicating lower problems, and therefore better quality of life. Min 0 - Max 100. Scale scores are computed as the sum of the items over the number of items answered.
Baseline
Group
Value
95% CI
Intervention Group
65.4
± 13.2
Control Group
65.1
± 15.6
6 months
Group
Value
95% CI
Intervention Group
66.7
± 11.3
Control Group
67.4
± 18.1
Asthma ControlPrimary· 6 months
Asthma control test (ACT) - presented as a total score with a lower score indicating poor control. Overall score above 19 would indicate well-controlled asthma. Min value 0 - Max 25.
Baseline
Group
Value
95% CI
Intervention Group
17.2
± 5.2
Control Group
17.4
± 4.5
6 months
Group
Value
95% CI
Intervention Group
16.9
± 4.1
Control Group
17.8
± 5.2
Episodes of Prescriptions of 3 or More Days of Prednisolone (or Similar)Primary· 6 months
Self-reported in a healthcare utilisation questionnaire.
Baseline
Group
Value
95% CI
Intervention Group
9
Control Group
11
Intervention Group
23
Control Group
21
6 months
Group
Value
95% CI
Intervention Group
5
Control Group
6
Intervention Group
13
Control Group
16
Attendance at Emergency Department for an Exacerbation of AsthmaSecondary· 6 months
Self-reported in a healthcare utilisation questionnaire
Baseline
Group
Value
95% CI
Intervention Group
5
Control Group
4
Intervention Group
27
Control Group
28
6 months
Group
Value
95% CI
Intervention Group
0
Control Group
2
Intervention Group
18
Control Group
20
Hospital Admission for an Exacerbation of AsthmaSecondary· 6 months
Self-reported in a healthcare utilisation questionnaire
Baseline
Group
Value
95% CI
Intervention Group
14
Control Group
17
Intervention Group
18
Control Group
15
6 months
Group
Value
95% CI
Intervention Group
0
Control Group
2
Intervention Group
18
Control Group
20
Paediatric Quality of LifeSecondary· 6 months
Paediatric asthma quality life questionnaire (PAQLQ) - presented as a total score. Higher scores represent a better quality of life. Min value 1 - max 7.
Baseline
Group
Value
95% CI
Intervention Group
4.5
± 1.6
Control Group
5.1
± 1.5
6 months
Group
Value
95% CI
Intervention Group
5.7
± 0.7
Control Group
4.6
± 1.5
Sponsor's own description
This trial will address the impaired quality of life of young people with asthma, despite appropriate medicines. Research shows that young people report needing to calm themselves down during an asthma attack to control their breathing. Although physiotherapist- delivered breathing retraining programmes now have a clear evidence base in adults with asthma, improving quality of life, there is a lack of evidence assessing its use in younger patients. The investigators have redesigned an adult training package to make it appropriate for young people and will now assess how effective such an intervention would be in this population. This study will include young people (12-17 years) with physician diagnosed asthma. The repurposing, optimisation and acceptability of the intervention in the adolescent age group has been undertaken in Stages 1 and 2 of the Breathe 4 Teens (BREATHE4T) project. A self-guided, breathing retraining digital intervention has been developed, delivered via a mobile friendly, online platform.
The current study is a randomised, controlled feasibility trial and will provide the necessary information for a substantive cost-effectiveness trial. Participants with access to the intervention will be compared to a usual care group. Asthma and quality of life of both groups will also be assessed at baseline, 2-month and 6-month time points. At the end of the 6 months, the control group will also be given access to the website.
The online nature of this study allows recruitment from across the United Kingdom. Recruitment methods would include primary care, hospital clinics, social media and posters. AsthmaUK will also provide publicity to assist recruitment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07427329 — Benefits of Physical Activity During the School Day to Reduce Mental Fatigue and Optimize Cognitive and Psychosocial Pro
· NA
· active not recruiting
NCT07029919 — Personalized Approach To Habits - Sleep
· NA
· recruiting
NCT06894277 — Internet-based Talking About Risk and Adolescent Choices: Health and Emotion Regulation Options
· NA
· recruiting
NCT06576076 — Cannabis, Linked Emotions, and Adolescent Risk Study
· NA
· recruiting
NCT06670066 — Rigorous Evaluation of Let's Talk Birth Control
· NA
· recruiting
Other University of Southampton trials
Trials by the same sponsor.
NCT07531277 — Developing Resource Interventions for Healthcare Professionals and Patients to Improve Knowledge About Fertility in Prim
· NA
· not yet recruiting
NCT06923943 — Predicting Nurse Staffing Requirements From Routinely Collected Data
· active not recruiting
NCT06692959 — A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
· Phase 2
· recruiting
NCT06815120 — A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent
· NA
· not yet recruiting
NCT06566157 — PROMOTE: The Effect of a Six Week Prebiotic Supplementation on Wellbeing of Young Adults.
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Southampton
Last refreshed: 17 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006703.